Market Access News | pharmaphorum

News

AZ files for emergency use of COVID-19 antibody combo in US

AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent symptomatic COVID-19 infection when given to healt

News

Joy as sickle cell patients get access to Novartis' Adakveo ...

People living with sickle cell disease (SCD) in England and Wales will be able to get access to treatment with Novartis' Adakveo, thanks to a special arrangement between the drugmaker and N

News

NICE clears NHS use of Roche's Tecentriq in bladder cancer

NICE has recommended routine NHS access to Roche's cancer immunotherapy Tecentriq for some bladder cancer patients, four years after it was first made available via the Cancer Drugs Fund (C

News

AbbVie's Qulipta cleared for migraine prevention, setting up...

AbbVie has added a third drug to its arsenal in the crowded migraine market, getting FDA approval for Qulipta – its once-daily oral preventive therapy for episodic migraines.

News

Closeup of X-ray photography of human brain

Biogen, Eisai double down on Alzheimer's with lecanemab fili...

Biogen and Eisai's first Alzheimer's disease drug Aduhelm is facing an uphill battle in the US market, but the partners are forging ahead with their second candidate lecanemab, starting a r

News

Takeda bags Japanese approval for Crohn's cell therapy Alofi...

Takeda has chalked up another milestone for its Alofisel cell therapy for a complication of Crohn's disease, becoming the first allogeneic stem cell therapy to be approved in Japan.

AZ files for emergency use of COVID-19 antibody combo in US

Joy as sickle cell patients get access to Novartis' Adakveo ...

NICE clears NHS use of Roche's Tecentriq in bladder cancer

AbbVie's Qulipta cleared for migraine prevention, setting up...

Biogen, Eisai double down on Alzheimer's with lecanemab fili...

Takeda bags Japanese approval for Crohn's cell therapy Alofi...

Datroway joins Trodelvy for frontline TNBC in the EU

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks